LRRK2-Targeting Therapies March Through the Valley of Death

Mov Disord. 2023 Mar;38(3):361-365. doi: 10.1002/mds.29343.
No abstract available

Keywords: clinical trials; leucine-rich repeat kinase 2; neuroprotectants.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Humans
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2* / genetics

Substances

  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • LRRK2 protein, human